| Andrew Nathanson, MD | |
|
593 Eddy St, Claverick 2, Providence, RI 02903-4923 | |
| (401) 519-1604 | |
| (401) 272-0538 |
| Full Name | Andrew Nathanson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 34 Years |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134133804 | NPI | - | NPPES |
| 11/12/2009 | Other | RI | NHPRI |
| 1134133804 | Other | RI | NPI |
| 7004160 | Medicaid | RI | |
| 07/01/2007 | Other | RI | BCBS |
| 12/29/2008 | Other | MA | TUFTS HEALTH PLAN |
| 3186393 | Medicaid | MA | |
| 939025129 | Other | RI | RI MEDICARE GROUP NUMBER |
| 04/15/2009 | Other | RI | UNITED HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD08737 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brown Emergency Medicine | 7214833169 | 141 |
News Archive
Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.
A new study published in January 2020 in the journal Scientific Reports reports the presence of a new lineage of enterovirus responsible for the hand-foot-and-mouth disease (HFMD). They think this could be more virulent than the earlier B5 subtype.
At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 2 days ago
| Entity Name | Brown Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962455022 PECOS PAC ID: 7214833169 Enrollment ID: O20040116000868 |
News Archive
Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.
A new study published in January 2020 in the journal Scientific Reports reports the presence of a new lineage of enterovirus responsible for the hand-foot-and-mouth disease (HFMD). They think this could be more virulent than the earlier B5 subtype.
At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 2 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.
A new study published in January 2020 in the journal Scientific Reports reports the presence of a new lineage of enterovirus responsible for the hand-foot-and-mouth disease (HFMD). They think this could be more virulent than the earlier B5 subtype.
At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Nathanson, MD Po Box 9484, Providence, RI 02940-9484 Ph: (401) 854-2500 | Andrew Nathanson, MD 593 Eddy St, Claverick 2, Providence, RI 02903-4923 Ph: (401) 519-1604 |
News Archive
Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.
A new study published in January 2020 in the journal Scientific Reports reports the presence of a new lineage of enterovirus responsible for the hand-foot-and-mouth disease (HFMD). They think this could be more virulent than the earlier B5 subtype.
At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.
Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.
Scientists at the Cancer Prevention Institute of California (CPIC), Stanford University, and the University of Southern California/Keck School of Medicine have found that while Hispanics have much lower risks of developing melanoma than non-Hispanic whites in California, they develop the disease at younger ages, develop thicker tumors, which are more difficult to treat, and experience a higher percentage of cases among people living in poorer neighborhoods.
› Verified 2 days ago
Dr. Robert A Partridge, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-519-1604 Fax: 401-272-0538 | |
Dr. Gregory R Lockhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-444-4000 Fax: 401-427-7795 | |
Ian M Jacobson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 330-493-4443 | |
Dr. Daniel Shanin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Carli Renske Reisdorf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6680 | |
Dr. Oriane Diana Longerstaey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 704-355-3181 | |
Rachel Smith Shain, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6489 Fax: 401-444-6662 |